Sortilin exhibits tumor suppressor-like activity by limiting EGFR transducing function
E. Lapeyronnie, C. Granet, J. Tricard, P. Gallet, M. Yassine, A. Chermat, M. O. Jauberteau, B. Melloni, F. Vincent, T. Naves, F. Lalloue
This study shows sortilin limits EGFR's transducing function by interacting with gene regulatory elements, suggesting it may predict anti-EGFR therapy efficacy in lung adenocarcinoma.
bioRxiv · May 12, 2021 · PreprintCancer Biology